In a large multicentre sample of cognitively normal subjects, as a function of age, gender
and APOE genotype, we studied the frequency of abnormal cerebrospinal fluid levels of …

There is increasing interest in the value of CSF biomarkers to predict those individuals with
mild cognitive impairment who will progress to dementia. However, lumbar puncture is not …

Objectives–Multiple sclerosis (MS) frequently causes disturbances of autonomic functions.
Cardiovascular dysautonomia has been studied by classic autonomic tests and, recently, by …

Previous studies have indicated the potential of cerebrospinal fluid (CSF) α‐synuclein (α‐
syn) to be an additional biomarker for improving differential diagnosis of Alzheimer's disease …

Background: Alzheimer's disease (AD) is characterized by the presence of β-amyloid
plaques and neurofibrillary tangles, while Lewy body dementia (LBD) is characterized by α …

Aim To perform a meta-analysis of the diagnostic yield of this technique for the prediction of
patients with MCI who are going to progress to AD. Materials and methods A search was …

Background Alzheimer's disease (AD) accompanied by psychotic symptoms (PS) has a poor
prognosis and may be associated with imbalances in key neural proteins such as alpha …

Objectives. To evaluate the association between apolipoprotein E (APOE) genotype and
cerebrospinal fluid (CSF) levels of Alzheimer's disease (AD) biomarkers and to study the …

Background: Behavioral and psychological symptoms of dementia (BPSD) are difficult to
manage and associated with poor outcome. Objectives: The aim of this study was to reach …

Cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) are currently being
assessed with two different assays. Our objective was to study if there is a correlation …